Michael P. Dube, VP, Chief Accounting Officer: Intellia Therapeutics NTLA Sell · Filed 25/10/03

Trade details

Type: Insider sale
Amount: $32,517.98
Shares · price: 1,871 sh · $17.38 a share
Held after: 55,266 sh
Stock: Intellia Therapeutics NTLA
Person: Michael P. DubeVP, Chief Accounting Officer
Trade date: 25/10/01
Filed: 25/10/03
Days to filing: 2 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/01~25/10/31

Michael P. Dube's recent trades

Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$27.5K
2,989 sh
$27.5K
Filed 01/07
Traded 01/05
Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$24.9K
2,503 sh
$24.9K
Filed 25/07/03
Traded 25/07/02
Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$16.7K
1,372 sh
$16.7K
Filed 25/01/07
Traded 25/01/03
Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$38.2K
2,012 sh
$38.2K
Filed 24/10/04
Traded 24/10/02